Download
41380_2024_Article_2531.pdf 2,99MB
WeightNameValue
1000 Titel
  • Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
1000 Autor/in
  1. Gaitonde, Supriya A. |
  2. Avet, Charlotte |
  3. de la Fuente Revenga, Mario |
  4. Blondel-Tepaz, Elodie |
  5. Shahraki, Aida |
  6. Pastor, Adrian Morales |
  7. Talagayev, Valerij |
  8. Robledo, Patricia |
  9. Kolb, Peter |
  10. Selent, Jana |
  11. Gonzalez-Maeso, JAVIER |
  12. Bouvier, Michel |
1000 Verlag
  • Nature Publishing Group UK
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-02
1000 Erschienen in
1000 Quellenangabe
  • 29(9):2753-2764
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41380-024-02531-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420065/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>The intricate involvement of the serotonin 5-HT<jats:sub>2A</jats:sub> receptor (5-HT<jats:sub>2A</jats:sub>R) both in schizophrenia and in the activity of antipsychotic drugs is widely acknowledged. The currently marketed antipsychotic drugs, although effective in managing the symptoms of schizophrenia to a certain extent, are not without their repertoire of serious side effects. There is a need for better therapeutics to treat schizophrenia for which understanding the mechanism of action of the current antipsychotic drugs is imperative. With bioluminescence resonance energy transfer (BRET) assays, we trace the signaling signature of six antipsychotic drugs belonging to three generations at the 5-HT<jats:sub>2A</jats:sub>R for the entire spectrum of signaling pathways activated by serotonin (5-HT). The antipsychotic drugs display previously unidentified pathway preference at the level of the individual Gα subunits and β-arrestins. In particular, risperidone, clozapine, olanzapine and haloperidol showed G protein-selective inverse agonist activity. In addition, G protein-selective partial agonism was found for aripiprazole and cariprazine. Pathway-specific apparent dissociation constants determined from functional analyses revealed distinct coupling-modulating capacities of the tested antipsychotics at the different 5-HT-activated pathways. Computational analyses of the pharmacological and structural fingerprints support a mechanistically based clustering that recapitulate the clinical classification (typical/first generation, atypical/second generation, third generation) of the antipsychotic drugs. The study provides a new framework to functionally classify antipsychotics that should represent a useful tool for the identification of better and safer neuropsychiatric drugs and allows formulating hypotheses on the links between specific signaling cascades and in the clinical outcomes of the existing drugs.</jats:p>
1000 Sacherschließung
lokal Olanzapine/pharmacology [MeSH]
lokal Receptor, Serotonin, 5-HT2A/drug effects [MeSH]
lokal Haloperidol/pharmacology [MeSH]
lokal /14/5
lokal Schizophrenia/drug therapy [MeSH]
lokal /96/10
lokal Antipsychotic Agents/pharmacology [MeSH]
lokal /13/109
lokal Signal Transduction/drug effects [MeSH]
lokal Clozapine/pharmacology [MeSH]
lokal Aripiprazole/pharmacology [MeSH]
lokal Serotonin 5-HT2 Receptor Agonists/pharmacology [MeSH]
lokal Serotonin/metabolism [MeSH]
lokal /82/80
lokal Risperidone/pharmacology [MeSH]
lokal Humans [MeSH]
lokal /631/154
lokal Receptor, Serotonin, 5-HT2A/metabolism [MeSH]
lokal /692/699/476/1799
lokal Article
lokal /96/106
lokal /14/35
lokal HEK293 Cells [MeSH]
lokal Schizophrenia/metabolism [MeSH]
lokal /13/95
lokal /14/33
lokal /631/1647
lokal article
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R2FpdG9uZGUsIFN1cHJpeWEgQS4=|https://frl.publisso.de/adhoc/uri/QXZldCwgQ2hhcmxvdHRl|https://frl.publisso.de/adhoc/uri/ZGUgbGEgRnVlbnRlIFJldmVuZ2EsIE1hcmlv|https://frl.publisso.de/adhoc/uri/QmxvbmRlbC1UZXBheiwgRWxvZGll|https://frl.publisso.de/adhoc/uri/U2hhaHJha2ksIEFpZGE=|https://frl.publisso.de/adhoc/uri/UGFzdG9yLCBBZHJpYW4gTW9yYWxlcw==|https://orcid.org/0000-0002-1907-9594|https://orcid.org/0000-0002-7941-0939|https://orcid.org/0000-0003-4089-614X|https://frl.publisso.de/adhoc/uri/U2VsZW50LCBKYW5h|https://orcid.org/0000-0003-3105-3204|https://orcid.org/0000-0003-1128-0100
1000 Hinweis
  • DeepGreen-ID: 1ee704a4158a4d1c96282e40459845a8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6522659.rdf
1000 Erstellt am 2025-07-06T16:12:55.050+0200
1000 Erstellt von 322
1000 beschreibt frl:6522659
1000 Zuletzt bearbeitet 2025-07-29T22:38:57.221+0200
1000 Objekt bearb. Tue Jul 29 22:38:57 CEST 2025
1000 Vgl. frl:6522659
1000 Oai Id
  1. oai:frl.publisso.de:frl:6522659 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source